Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
Janssen MM, Snoek FJ, Masurel N, Hoogma RP, Devillé WL, Popp-Snijders C, Heine RJ. Janssen MM, et al. Among authors: snoek fj. Diabetes Care. 2000 May;23(5):629-33. doi: 10.2337/diacare.23.5.629. Diabetes Care. 2000. PMID: 10834421 Clinical Trial.
Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes.
Swinnen SG, Snoek FJ, Dain MP, DeVries JH, Hoekstra JB, Holleman F. Swinnen SG, et al. Among authors: snoek fj. Diabetes Technol Ther. 2009 Nov;11(11):739-43. doi: 10.1089/dia.2009.0044. Diabetes Technol Ther. 2009. PMID: 19905891 Clinical Trial.
290 results